Hepatic miR-378 targets p110α and controls glucose and lipid homeostasis by modulating hepatic insulin signalling.
about
'Micro-managers' of hepatic lipid metabolism and NAFLDRegulatory Roles of MicroRNAs in DiabetesHepatocyte TRAF3 promotes liver steatosis and systemic insulin resistance through targeting TAK1-dependent signallingmiR-378 Activates the Pyruvate-PEP Futile Cycle and Enhances Lipolysis to Ameliorate Obesity in MiceMicroRNA-124 promotes hepatic triglyceride accumulation through targeting tribbles homolog 3.The E3 ligase tripartite motif 8 targets TAK1 to promote insulin resistance and steatohepatitis.Oscillating primary transcripts harbor miRNAs with circadian functionsMicroRNAs as paracrine signaling mediators in cancers and metabolic diseases.miRNAs Caught Up in Metabolic Organ Crosstalk to Combat Obesity.miRNA Signatures of Insulin Resistance in Obesity.Hepatic leukocyte immunoglobulin-like receptor B4 (LILRB4) attenuates nonalcoholic fatty liver disease via SHP1-TRAF6 pathway.The long non-coding RNA Gm10768 activates hepatic gluconeogenesis by sequestering microRNA-214 in mice.Severity of Systemic Inflammatory Response Syndrome Affects the Blood Levels of Circulating Inflammatory-Relevant MicroRNAs.The Destiny of Glucose from a MicroRNA Perspective.AICAR enhances insulin signaling via downregulation of miR-29.Noncoding RNAs Carried by Extracellular Vesicles in Endocrine Diseases.
P2860
Q26801228-75C423AB-E2D0-4361-83DD-AB921CDB943EQ28069612-420C1BF2-B878-498E-B97A-646B08AA5D54Q36591276-9B5F5E99-2399-4F09-84E7-5D5DC7FD8791Q36754143-0E0E5BCA-2576-4C84-8C92-A85F1B3F4F86Q37413876-ED2E5F8E-3BB8-4423-95A3-8C66A21C0454Q38289759-73414D1C-553E-4C65-AB9F-A108BB41034AQ38582424-DE77CBC6-4BDE-4998-B5AD-3CFE80C15E03Q39030840-AEE88310-66DC-497D-9606-B586D003E954Q39761834-AF0C4F9D-7643-4806-8242-BCDC3D025D94Q48188041-27D5F462-D388-4207-893A-7D500E1F6D2EQ48614912-72AC8186-56BE-4B6C-B4E0-637A11CDED82Q49832345-3BD36F21-A71D-478F-8485-283F5491C516Q50090767-7F2E7A0B-EC57-4E2C-AC71-0C199E0180DAQ52657176-D7E1A5AF-1D7C-4293-B56B-9ECB349063F3Q55043236-3EE574BB-B0F6-4BD4-94B4-1B6CE39E3566Q55052671-E1A2D6EF-7DB8-42E1-835F-23832712B19C
P2860
Hepatic miR-378 targets p110α and controls glucose and lipid homeostasis by modulating hepatic insulin signalling.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Hepatic miR-378 targets p110α ...... ng hepatic insulin signalling.
@en
type
label
Hepatic miR-378 targets p110α ...... ng hepatic insulin signalling.
@en
prefLabel
Hepatic miR-378 targets p110α ...... ng hepatic insulin signalling.
@en
P2093
P2860
P356
P1476
Hepatic miR-378 targets p110α ...... ing hepatic insulin signalling
@en
P2093
Cunjie Chang
Hongchao Cao
Hongfeng Xia
Jingjing Jiang
Minghua Lu
Mo-Fang Liu
P2860
P2888
P356
10.1038/NCOMMS6684
P407
P50
P577
2014-12-04T00:00:00Z
P5875
P6179
1003269208